CCR12P

Across TCGA pan-cancer cohorts, CCR12P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CCR12P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where CCR12P RNA is repressed in tumor relative to normal tissue. In most cancer types CCR12P is over-expressed in tumor, although a few such as COAD and THCA show the opposite, repressed pattern.

COAD and THCA are the cancer types where CCR12P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCR12P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	−0.100	<.001	6	view →
THCA	All	All	−0.122	.013	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

CCR12P–COAD

Open the COAD breakdown →